NVS — Novartis AG
In 2026 Q2, 9 of the 140 tracked hedge funds reported a position in Novartis AG (NVS), worth $263.68M combined. Over the quarter 2 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $123.50M | 0.17% | -29.1% |
| VanEck | $99.29M | 0.06% | -29% |
| Quadrature | $37.70M | 0.32% | +110.5% |
| IMC | $1.53M | 0.01% | NEW |
| Steadtrust | $904.12K | 0.46% | +0% |
| Essex | $293.85K | 0.04% | NO CHANGE |
| O'Keefe | $215.18K | 0.04% | NO CHANGE |
| Barnes Dennig | $166.12K | 0.13% | -2.4% |
| Parvin | $82.28K | 0.07% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.